VKH
RDY icon

Virtu KCG Holdings’s Dr. Reddy's Laboratories RDY Stock Holding History

Virtu KCG Holdings’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-33,350
Closed -$302K – 3636
2016
Q4 		$302K Buy
+33,350
New +$310K 0.01% 2090
2015
Q1 		– Sell
-24,160
Closed -$244K – 3742
2014
Q4 		$244K Buy
+24,160
New +$254K ﹤0.01% 2621
2014
Q2 		– Sell
-45,200
Closed -$397K – 3987
2014
Q1 		$397K Buy
45,200
+13,075
+41% +$114K ﹤0.01% 2222
2013
Q4 		$264K Buy
+32,125
New +$254K ﹤0.01% 2774

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu KCG Holdings's RDY Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Dr. Reddy's Laboratories (RDY) in Q1 2017, closing a stake of 33,350 shares — an estimated $302K sold.

Virtu KCG Holdings first reported a position in RDY in Q4 2013 and held it in 4 quarters. The position peaked at $397K in Q1 2014. 134 funds tracked by Wall St. Rank hold RDY as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Dr. Reddy's Laboratories position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 33,350 Dr. Reddy's Laboratories shares in Q1 2017, an estimated $302K.
  • Virtu KCG Holdings first reported a position in Dr. Reddy's Laboratories in Q4 2013 and held it in 4 quarters.
  • Virtu KCG Holdings's Dr. Reddy's Laboratories position peaked at $397K in Q1 2014.
  • 134 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.